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T1 Independent, T*2 Corrected Chemical Shift Based
Fat–Water Separation With Multi-peak Fat Spectral
Modeling Is an Accurate and Precise Measure of
Hepatic Steatosis
Catherine D.G. Hines, PhD,1 Alex Frydrychowicz, MD,1,2 Gavin Hamilton, PhD,3
Dana L. Tudorascu, PhD,4 Karl K. Vigen, PhD,1 Huanzhou Yu, PhD,5
Charles A. McKenzie, PhD,6 Claude B. Sirlin, MD,3
Jean H. Brittain, PhD,7 and Scott B. Reeder, MD, PhD1,8*
Results: Statistical analysis demonstrated excellent
precision of MRI and MRS fat-fractions, indicated by
95% conﬁdence intervals (units of absolute percent)
of [2.66%,2.64%] for single MRI ROI measurements,
[0.81%,0.80%]
for
averaged
MRI
ROI,
and
[2.70%,2.87%] for single-voxel MRS. Linear regression
between MRI and MRS indicated that the MRI method is
highly accurate. Sensitivity and speciﬁcity for detection of
steatosis using averaged MRI ROI were 100% and 94%,
respectively. The relationship between hepatic fat-fraction
and body mass index was examined.

Purpose: To determine the precision and accuracy of hepatic fat-fraction measured with a chemical shift-based
MRI fat-water separation method, using single-voxel MR
spectroscopy (MRS) as a reference standard.
Materials and Methods: In 42 patients, two repeated
measurements were made using a T1-independent, T2 corrected chemical shift-based fat-water separation
method with multi-peak spectral modeling of fat, and T2corrected single voxel MR spectroscopy. Precision was
assessed through calculation of Bland-Altman plots and
concordance correlation intervals. Accuracy was assessed
through linear regression between MRI and MRS. Sensitivity and speciﬁcity of MRI fat-fractions for diagnosis of
steatosis using MRS as a reference standard were also
calculated.

Conclusion: Fat-fraction measured with T1-independent
T2 -corrected MRI and multi-peak spectral modeling of fat
is a highly precise and accurate method of quantifying
hepatic steatosis.
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NONALCOHOLIC FATTY LIVER disease (NAFLD) is the
most common cause of chronic liver disease in Western societies with an increasing prevalence that parallels current epidemics of obesity and diabetes (1,2).
NAFLD is considered by many to be the hepatic manifestation of the metabolic syndrome, a constellation of
diseases including adult-onset diabetes (type II), hyperlipidemia, and obesity (3,4). Individuals with NAFLD
can progress to a more aggressive form of NAFLD
known as nonalcoholic steatohepatitis (NASH), which
is characterized by inﬂammation, ballooning degeneration and ﬁbrosis, in addition to steatosis (5,6). Many
patients with steatohepatitis progress to end-stage ﬁbrosis (cirrhosis), which predisposes patients to hepatocellular carcinoma (HCC) and liver failure (7,8).
Intracellular accumulation of triglycerides and fatty
acids (steatosis) is the earliest and hallmark histological feature of NAFLD. Deﬁnitive diagnosis of NAFLD
and grading of steatosis requires biopsy, which is
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regarded as the clinical gold standard test and is the
current standard of care. Biopsy, however, is limited
by cost, high sampling variability (9), and other signiﬁcant risks that limit its utility for repeated evaluation
of liver disease. For these reasons, a noninvasive, costeffective, and quantitative alternative to biopsy is
needed for accurate quantiﬁcation of hepatic steatosis.
MRI is highly sensitive to the presence of fat due to
differences in chemical shift between water and fat.
MR spectroscopy (MRS) is considered by many to be
the noninvasive reference standard for quantiﬁcation
of hepatic fat content (10,11). MRS has both higher
sensitivity and speciﬁcity for hepatic fat quantiﬁcation
compared with ultrasound and computed tomography
(12), indicating that an MR-based technique would be
advantageous for hepatic fat quantiﬁcation. However,
like biopsy, MRS is prone to sampling error due to the
heterogeneity of steatosis because typically only a single voxel is used to assess the entire liver. Alternatively, chemical shift based water–fat separation
methods have demonstrated accurate quantiﬁcation
of hepatic steatosis by several groups (11,13–17).
Several confounding factors have been identiﬁed
that corrupt the ability of MRI to accurately quantify
fat using fat–water separation techniques (18). These
factors must be addressed before the measured fatfraction accurately reﬂects the underlying concentration of triglycerides. Speciﬁc confounding factors
include T1 bias (13,19–21), noise bias (19), the complex NMR spectrum of fat (13,14,22), T2 decay
(13,23), and phase errors caused by eddy currents
(24). To perform the correction for eddy currents, a
complex image-based fat–water separation including
spectral modeling and T2 correction is performed ﬁrst.
Then, a second ﬁt to a magnitude signal model is performed, using the complex estimates of water, fat and
T2 as the starting conditions. This provides estimates
of water and fat that are free from the effects of phase
shifts from eddy currents. After correction for all confounding factors, the measured fat-fraction is equivalent to the proton density fat-fraction (PDFF). PDFF is
an inherent property of the tissue, and is platform
and protocol independent, making it a potentially useful biomarker of liver fat content.
A recently described complex chemical shift-based
fat-water separation method, based on IDEAL (Iterative
Decomposition of water and fat with Echo Asymmetry
and Least squares estimation) has been described for
fat quantiﬁcation in the liver (14,19,22,23,25). Using a
low ﬂip angle to minimize T1 bias (19), magnitude discrimination to minimize noise bias (19), T2 correction
(22,23), multi-peak fat spectral modeling (14,22)
including six spectral peaks of fat, and eddy current
correction (24), accurate quantiﬁcation has been validated in phantom experiments (26), animal experiments (17) and more recently in in vivo studies (25),
over a wide range of fat-fractions (17,26). These studies collectively provide validation on the accuracy of
this method.
However, rigorous validation of a biomarker also
requires an understanding of the precision (repeatability) of a method to assess longitudinal changes in
the biomarker. Therefore the primary purpose of this
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work is to determine the precision of clinical MRI hepatic fat quantiﬁcation when correction for all known
confounding factors has been performed. A secondary
purpose is to reproduce accuracy measurements
reported in previous validation studies (25), using MRS
as the reference standard for hepatic fat-fraction.

PATIENTS AND METHODS
Patients
After obtaining IRB approval and informed consent,
42 patients (22 male, 20 female) referred to the
Department of Radiology for abdominal MRI were
recruited for this study, irrespective of diagnosis,
between September 16, 2009 and August 20, 2010.
Mean age for all patients was 51.0 6 13.1 years
(range, 23–80 years). Thirty-ﬁve of these patients had
height and weight recorded in the medical record;
these patients had a mean weight of 82.0 6 25.8 kg
(range, 50.3–207 kg), and a mean body mass index
(BMI) of 24.6 6 5.5 kg/m2 (range, 19.1–45.3 kg/m2).
All patients over the age of 18 were eligible for this
study, and no patients were excluded, unless they
declined to consent to the study.
Imaging Protocol
Imaging was performed on three 1.5 Tesla (T) clinical
scanners (Signa HDx, GE Healthcare, Waukesha, WI)
using an eight-channel phased array cardiac coil or
eight-channel body phased array coil.
For each patient, two repeated measurements of a
quantitative chemical shift-based water–fat separation
MRI method and a single voxel MRS were made to
assess repeatability (precision) of both techniques.
Between each measurement (‘‘Time 1’’ and ‘‘Time 2’’),
the patient was removed from the magnet, and the anterior coil elements only removed. The patient was
instructed to sit up and then lie down, after which the
anterior coil was repositioned and the patient placed
back into the magnet without disturbing the posterior
coil. New landmarks and new localizers were acquired,
and all prescanning was repeated, followed by represcription of the MRI and MRS sequences to simulate a new, independent exam.
For volumetric MRI fat-fraction imaging, an investigational version of the three-dimensional spoiled gradient echo (SPGR) IDEAL sequence was used (27).
Using ﬂy-back readouts, a total of six echoes were
acquired per TR, and a 2D parallel imaging acceleration method (ARC) (28,29), which had an effective
net acceleration of 2.2, was used to reduce the total
imaging time to 21 s. Imaging parameters for the
MRI sequence were: ﬁrst TE ¼ 1.3 ms, echo spacing ¼
2.0 ms, TR ¼ 13.7 ms, BW ¼ 6 125 kHz, FOV ¼ 35 
35 cm, slice ¼ 10 mm, 256  128 matrix, ﬂip ¼ 5
to reduce T1 bias (19), and 24 slices in the superior/
inferior direction. Thus, complete liver coverage was
acquired in one breath-hold, with true spatial resolution of 1.4  2.7  10 mm.
Single voxel breath-held MRS data were acquired to
provide a reference fat-fraction. Spectra were acquired
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using an investigational version of STEAM (Stimulated
Echo Acquisition Mode) without water suppression. A
2.5  2.5  2.5 cm3 MRS voxel was placed in the posterior segment (Couinaud segments 6 or 7) of the right
hepatic lobe while avoiding large vessels in the same
attempted location for both acquisitions, but without
reference to images from the ﬁrst time point. Imaging
parameters for MRS included the following: TR ¼
3500 ms, 2048 readout points, 1 average, and spectral width (receiver bandwidth) ¼ 62.5 kHz. To perform T2 correction in postprocessing, echo times of
10, 20, 30, 40, and 50 ms were acquired (30), within
a single 21-s breath hold.

tion (SVD)-based approach to combine the signals
from individual coils was used (33). Spectra were then
read into jMRUI and analyzed using the AMARES
algorithm. Using prior knowledge, the total fat signal
was calculated by summing the signals from peaks
located at identical locations as the multi-peak fat
spectrum used for MRI (30). The water and fat signals
were corrected for T2 relaxation by nonlinear ﬁtting of
the peaks areas from the different TEs. A priori
knowledge of the fat spectrum was then used to correct for the fat peaks near or under the water peak to
give a T2-corrected MRS fat-fraction (34,35).
Statistical Analysis

Postprocessing and Image Reconstruction
An investigational, modiﬁed IDEAL water–fat estimation reconstruction was used to correct for confounding factors of T2 decay, multiple spectral peaks of fat,
noise bias, and eddy currents. Reconstructed images
were displayed and edited in DICOM format. ROI
analysis was performed on the DICOMs on a GE
Advantage workstation (GE Healthcare, Waukesha,
WI). Researchers commonly assess fat content in the
liver using ‘‘signal fat-fraction,’’ which is a useful metric that is independent of B1 coil sensitivity proﬁles,
providing a normalized measurement of fat concentration. Signal fat-fraction (h) images are generated on a
pixel-by-pixel basis using fat images (Sf) and water
images (Sw), where:
h¼

Sf
Sf þ Sw

½1

When all confounding factors have been accounted
for and/or corrected, the signal fat-fraction is equivalent to the PDFF, which is the ratio of unconfounded
signal from all mobile protons of fat, and the sum of
the total unconfounded signal from mobile protons in
water and fat. For the purposes of this work, we will
use the term ‘‘fat-fraction’’ for brevity.
Because estimates of R2 (¼1/T2 ) are generated as
part of T2 correction, as described by Yu et al (23), an
R2 map is also generated, where the estimated value
of R2 is displayed on a pixel-by-pixel basis throughout
the liver. This T2 correction method assumed a that
water and fat have the same T2 decay in a voxel.
A ﬂip angle of 5 was used to minimize T1 bias,
although simulations have shown that small residual
T1 bias may remain (31). However, methods exist to
correct for this bias (13,31), using assumed values of
T1 for fat and water of 343 ms and 586 ms, respectively, as previously reported (32). The amount of T1
bias was calculated using the TR and assumed values
for the T1 of fat and water, and used to correct the
estimated MRI fat-fractions (31). Using simulation
results, T1 bias correction was performed separately
from the image reconstruction using measured MRI
fat-fractions in Excel.
A single operator at a separate institution blinded to
time points and patient information performed the
MRS postprocessing using jMRUI (31). A Matlab
based program that uses a singular-value decomposi-

Two independent readers recorded fat-fraction and R2
from the reconstructed fat-fraction and R2 maps,
respectively, measured in nine regions of interest
(ROIs) corresponding to each of the nine Couinaud
segments. Because the vascular anatomy was difﬁcult
to visualize on fat-fraction images when the fat-fraction was low, ROIs were selected on water images and
copied to the identical location of the corresponding
fat-fraction images and R2 maps. In this way, any
bias caused by immediate feedback from seeing the
ROI value on the monitor during ROI positioning was
avoided. Care was taken to avoid large blood vessels
and any liver lesions for ROI selection. ROIs from
individual segments were matched to the anatomy
between Time 1 and Time 2 to the best of each reader’s ability. ROIs were identical in size between individual segments for the two time points.
In addition, an ROI was placed at the same location
in the MRI fat-fraction image as the MRS voxel using
the location of the MRS voxel, which was recorded in
the spectroscopy ﬁle. Three ROIs of 2.5  2.5 cm2 were
recorded to more closely reﬂect the three-dimensional
shape of the MRS voxel. One ROI was measured at the
recorded location of the MRS voxel, which was at the
center of the MRS voxel, and an identical ROI was copied to the slices immediately superior and inferior to
the center slice. The measurements from the three
ROIs were averaged to report a MRI fat-fraction at the
location of the MRS voxel. Because both readers would
record an identical ROI using the recorded voxel location, an MRI ROI measurement at the location of the
MRS voxel was performed for Reader 1 only.
Subsequent analysis was performed on the nine
individual fat-fraction ROIs recorded in the Couinaud
segments, one fat-fraction ROI at the location of the
MRS voxel, and an average fat-fraction of the ROIs
recorded in the Couinaud segments; a weighted average by size of ROI was calculated such that an average fat-fraction across the entire liver was reported.
ROIs differed in size for each segment, although average ROI size was 152 pixels (range, 55–751 pixels,
maximum and minimum located in segments 1 and 8,
respectively).
Precision of MRI fat-fraction measurements was
assessed through Bland-Altman analysis between time
points for both readers using individual ROIs and average fat-fraction across the liver. Bland-Altman plots
were also generated for MRS data between time points
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Figure 1. Representative patient fat-fraction images and MRS spectra at Time 1 and Time 2. Patient 1, Patient 2, and Patient
3 are examples of severely elevated fat-fraction, mildly elevated fat-fraction, and a normal fat-fraction, respectively. The MRI
fat-fraction recorded at the location of the MRS voxel is displayed on each fat-fraction image. MRS fat-fractions are as indicated on the spectra. Excellent agreement is seen between time points for individual readers, between different readers, and
between techniques.

of processed spectra and for the MRI fat-fractions
acquired at the location of the MRS voxel. Precision of
MRI R2 measurements was also assessed through
Bland-Altman analysis between time points for both
readers using individual ROIs across the liver only.
Corresponding 95% conﬁdence intervals and concordance correlation coefﬁcients between each compared
data were also estimated (36).
Accuracy was assessed through linear regression
and calculation of the concordance correlation coefﬁcient between the MRI fat-fraction measurement
co-registered with the T2-corrected MRS fat-fraction
measurement pooled for Time 1 and Time 2, as
recorded by Reader 1. Two-sided t-tests were performed to determine whether statistically signiﬁcant
differences exist between estimated slope values and
1.0, and obtained intercept values and 0.0 (a ¼ 0.05).
Sensitivity and speciﬁcity for the diagnosis of steatosis, not separated by reader or time point, of the
MRI fat-fraction measured at the location of the MRS
voxel were calculated using MRS-determined 5.56%
as the diagnostic threshold of steatosis (15,37). Sensitivity and speciﬁcity, not separated by time point, of the
average fat-fraction across the liver were also calculated. The area under the receiver operating characteristic curve (AROC) was calculated for MRI fat-fractions
at the location of the MRS voxel and average MRI fatfractions using MRS as a reference.
Regression was performed between average MRI fatfraction and BMI for patients who had recorded height

and weight information (n ¼ 30), to determine
whether a relationship existed between hepatic fatfraction and BMI. Next, using a cutoff of a BMI of
25 kg/m2, patients were divided into two groups (BMI
above 25 kg/m2 and BMI below 25 kg/m2). Average
MRI fat-fractions from each group were plotted
against BMI. A modiﬁed Levene’s test was performed
on the average MRI fat-fractions of each BMI group.
The modiﬁcation of this test was based on deviations
from the median, rather than the mean, such that the
modiﬁed Levene’s test performed an analysis of
variance test based on absolute deviations from the
group median. Lastly, a linear regression between
average R2 values and average MRI fat-fractions for
both readers was performed to determine if a relationship existed between hepatic fat-fraction and R2 values.
Bland-Altman analysis, and linear regression were
performed using Excel (v10 SP3, Microsoft, Redmond,
WA). Calculation of concordance correlation coefﬁcients was performed using R v2.8.1 and the Levene’s
test and AROC calculations were performed using R v
2.10.0 (R Development Core Team, 2009) (38).

RESULTS
Figure 1 displays representative MRI fat-fraction
images and corresponding MRS spectra at Time 1 and
Time 2 of three patients in this study. Patient 1 (top
row) was referred for evaluation of a focal nodular
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Figure 2. Bland-Altman plot between Time 1 and Time 2 for
the MRI fat-fractions measured in each of the Couinaud segments for all volunteers, indicating high precision. The limits
of agreement for Reader 1 (circles) are [2.54%, 2.44%],
denoted as a heavy dashed line. The limits of agreement for
Reader 2 (squares) are [2.76%, 2.83%], denoted as a ﬁne
dashed line. If data from both readers is pooled, the limits of
agreement are [2.66%, 2.64%].

hyperplasia (not shown on this slice), but no known
liver disease otherwise, and displays an example of
abnormally elevated fat-fraction. Average MRI fat-fraction among both readers and time points was 33.4 6
0.7% and was 34.2 6 0.6% for MRS averaged over the
two measurements. Patient 2 (middle row) has a history of hepatitis C and cirrhosis. This patient had an
elevated MRI fat-fraction of 6.5 6 0.1% averaged
across readers and time points, and an MRS fat-fraction of 7.3 6 0.1% averaged across time points. Similarly, Patient 3 (bottom row) displays a normal fatfraction (15,37). Patient 3 had a history of renal cell
carcinoma, and underwent an MRI to rule out liver
metastases, although he/she has no history of diffuse
liver disease. Average MRI fat-fraction among both
readers and time points was 1.2 6 0.2%, and average
MRS fat-fraction was 1.3 6 0.2% across time points.
These examples indicate excellent agreement between
the two techniques, time points, and readers.
The average fat-fraction among males was 5.72 6
6.03% (range, 0.00–22.03%) and among females was
5.71 6 9.00% (range, 0.54–36.45%). A two-tailed
t-test showed no statistically signiﬁcant differences in
fat-fractions between genders (P ¼ 0.99).
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Figure 3. Bland-Altman plot between Time 1 and Time 2 for
average MRI fat-fraction across the liver. The limits of agreement for Reader 1 (circles), denoted as a heavy dashed line,
are [0.66%, 0.64%] and for Reader 2 (squares), denoted as a
ﬁne dashed line, are [0.94%, 0.93%]. If data from both readers is pooled, the limits of agreement are [0.81%, 0.80%].

Time 1 and Time 2 were not separated by reader (i.e.,
pooled), the limits of agreement are [2.66%, 2.64%].
Figure 3 displays a Bland-Altman plot of the average MRI fat-fraction across the liver for all patients
between Time 1 and Time 2 (41 points per reader). As
averaging reduces variability, the limits of agreement
were [0.66%, 0.64%] for Reader 1 and [0.93%,
0.93%] for Reader 2. When average MRI fat-fraction
across the liver were pooled the limits of agreement
were [0.81%, 0.79%] between Time 1 and 2.
Figure 4 displays a Bland-Altman plot between fatfractions from Time 1 and 2 for the MRS data (41
points); the limits of agreement were [2.69%, 2.87%].
Figure 5 displays a Bland-Altman plot between R2
measurements from Time 1 and 2 for both readers (369
points per reader). The limits of agreement of R2 measurements were [15.19 s1, 13.84 s1] for Reader 1
and [19.67 s1, 18.42 s1] for Reader 2. When not
separated by reader, the limits of agreement for R2
measurements were [17.39 s1, 16.23 s1]. The average R2 value for both readers and time points was
31.4 6 10.2 s1 (range, 9.3–182.8 s1), and the average
T2 value was 35.0 6 12.0 ms (range, 5.5–107.6 ms).

Precision
Figure 2 shows a Bland-Altman plot between MRI fatfraction measured at Time 1 and 2 for the nine measured ROIs in the Couinaud segments for both readers
(369 points per reader). These results demonstrate
both close agreement between readers and time
points, and that fat-fraction measured with MRI provides very precise fat-fractions. The limits of agreement encompass 95% of the data, are in units of
absolute percent, and effectively constitute the 95%
conﬁdence interval (CI). Results from Reader 1 were
slightly more precise than Reader 2, where the limits
of agreement were [2.54%, 2.44%] for Reader 1 and
[2.76%, 2.64%] for Reader 2. When the data for

Figure 4. Bland-Altman plot between Time 1 and Time 2 for
MRS fat-fraction. The limits of agreement are [2.70%,
2.87%].
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Figure 5. Bland-Altman plot between Time 1 and Time 2 for
R2 measurements. The limits of agreement for Reader 1
(circles), denoted as a heavy dashed line, are [15.19 s1,
13.84 s1], and for Reader 2 (squares), denoted as a ﬁne
dashed line, are [19.67 s1, 18.42 s1]. If data from both
readers is pooled, the limits of agreement are [17.39 s1,
16.23 s1].

As steatosis is known to be heterogeneous across
the liver (39), Figure 6 plots the standard deviation
over the liver against the average fat-fraction over the
liver to assess the variability across segments as a
function of the average fat-fraction. Data are shown for
Reader 1 at Time 1 and Time 2, where both the standard deviation and average are expressed in fat-fraction
percent (%). No patient had a fat-fraction below 0%
over the liver, although ROIs from individual segments
can be below 0% due to noise. Lower variance is seen
at low fat-fractions, but the variance is relatively independent from fat-fraction and plateaus at higher fatfractions. No strong correlation between the standard
deviation and average of the fat-fraction is seen since
obtained slope, intercept, and r2 is 0.07 6 0.01, 3.02
6 0.09, and 0.35, respectively.
Precision can be evaluated by the calculation of
concordance correlation coefﬁcients (rc), where values
of 1.0 correspond to perfect agreement. Correlation
between Time 1 and Time 2 for the MRS fat-fractions is
0.98. Correlation between Time 1 and Time 2 for Reader
1 (Reader 2) using the fat-fraction ROIs measured in
the Couinaud segments was 0.98 (0.97), and between
readers for Time 1 (Time 2) was 0.97 (0.98). Similarly,
correlation between Time 1 and Time 2 for Reader 1
(Reader 2) using the average fat-fraction across the liver
was 0.99 (0.99), and between readers for Time 1 (Time
2) was 0.99 (0.99). Similarly, correlation between R2
measurements between Time 1 and Time 2 for Reader 1
(Reader 2) was 0.71 (0.59), and between readers for
Time 1 (Time 2) was 0.71 (0.48). These results indicate
that the readers are in high agreement with each other,
and that both MRS and MRI show high agreement for
repeated measures. Furthermore, fat-fraction measured
with both MRI and MRS are highly precise, and that
these results are independent of reader.
Accuracy
MRI provides highly accurate measures of fat-fraction
using MRS as a reference standard, as seen by the
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Figure 6. Standard deviation over the liver versus average
fat-fraction over the liver for Reader 1 at Time 1 and Time 2.
Both axes are expressed in fat-fraction percent (%). A lower
variance is seen in most patients that have low fat-fractions.
In general, however, the variance of measurements was relatively independent as the variance plateaus at approximately
5% for a wide range of fat-fractions.

regression between MRI fat-fraction measured at the
MRS voxel location and MRS fat-fraction for Reader 1
in Figure 7. Perfect agreement would have a slope of
1.0 and an intercept of 0.0. Estimated slope, intercept, and r2 are 1.04 6 0.02, 0.06 6 0.21, and 0.96,
respectively. The slope and intercept are not signiﬁcantly different from 1.0 and 0.0, respectively (P ¼
0.07, and P ¼ 0.8, respectively). Of note, the intercept
indicates high accuracy, particularly at low fat-fractions. For comparison, the estimated slope, intercept,
and r2 for MRI fat-fraction measured at the MRS
voxel location without T1 bias correction versus MRS
fat-fraction (not shown, for brevity) are 1.09 6 0.02,
0.11 6 0.22, and 0.96, respectively, indicating slight

Figure 7. Linear regression of MRI fat-fraction measured in
the location of the MRS voxel and MRS fat-fraction indicates
high accuracy. Estimated slope, intercept, and r2 value are
1.04 6 0.02, 0.06 6 0.21, and 0.96, respectively. The slope
and intercept are not signiﬁcantly different from 1.0 and 0.0,
respectively. An inset zoom of the 0–10% region is shown in
the lower right hand corner. Heavy dashed line is unity, and
95% conﬁdence interval of the slope is as ﬁne dashed lines.
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overestimation of the fat-fraction by MRI without correction for residual T1 bias. Without correction for residual T1 bias, the slope of 1.09 is signiﬁcantly different from 1.0 (P ¼ 0.0006) although the intercept is
not signiﬁcantly different from 0.0 (P ¼ 0.6). The calculated concordance correlation coefﬁcient between
MRI fat-fraction at the location of the MRS voxel and
MRS fat-fractions was 0.977 for Time 1 and 0.976 for
Time 2. Concordance correlation between MRS fatfraction and average MRI fat-fractions across the liver
for Reader 1 at Time 1 (Time 2) was 0.74 (0.64) and
for Reader 2 at Time 1 (Time 2) was 0.75 (0.63).
Sensitivity and Speciﬁcity
Sensitivity and speciﬁcity for diagnosis of steatosis
were calculated using MRI fat-fractions colocalized to
the MRS voxel. A 5.56% fat-fraction as diagnostic
threshold for steatosis, using MRS as the reference
standard (37), was used. The fat-fraction measurements at the location of the MRS voxel had a sensitivity and speciﬁcity of 91% and 93%, respectively. Using
MRS as a reference, AROC for MRI fat-fraction measurements at the location of the MRS voxel was 0.97.
In addition to comparing the sensitivity and speciﬁcity of MRI fat-fractions colocalized to the MRS voxel, the
sensitivity and speciﬁcity of average MRI fat-fractions
were compared. As with the previous comparison, a
5.56% fat-fraction as diagnostic threshold for steatosis,
using MRS as the reference standard, was used. For the
average MRI fat-fractions across the liver, sensitivity
and speciﬁcity were 100% and 94%, respectively, for
both readers. Using MRS as a reference, AROC for average fat-fractions across the liver was 0.97.
Body Mass Index
An exponential relationship is seen between MRI fatfraction and body mass index (BMI), as shown in Figure 8A. MRI fat-fraction is pooled for both readers,
and the line of best ﬁt is y ¼ 0.165e0.1089x, with an r2
value of 0.55, indicating good agreement The data are
not linear and an exponential relationship empirically
ﬁt the data better than other types of curve ﬁtting
that were tested.
Using a cutoff of a BMI of 25 kg/m2, patients were
divided into two groups. Average MRI fat-fractions
were plotted against these two cutoff groups (above
25 and below 25) in Figure 8B. All patients with a
BMI under 25 have average MRI fat-fractions below
5.56% (range, 1.18%–2.25%), or the threshold of a
diagnostic indicator of steatosis. Patients with a BMI
above 25 display a wider range of fat-fractions (range,
1.04%–33.72%). Using a conﬁdence level of 0.05,
results of the modiﬁed Levene’s test indicated statistically signiﬁcant differences (P ¼ 0.0034) in the median of each BMI patient group.
Relationship Between R*2 and Fat-Fraction
In addition, no agreement is seen between R2 values
and average MRI fat-fractions. For both readers and
time points, the line of best ﬁt for R2 versus average

Figure 8. a: Regression of average MRI fat-fraction and BMI
displays an exponential relationship for pooled readers. Line
of best ﬁt is y ¼ 0.165e0.1089x and r2 is 0.55. b: Comparison
of average MRI fat-fraction versus patients with a BMI above
and below 25 kg/m2. All patients with a BMI below 25 kg/m2
have fat-fractions that are considered normal or healthy,
although a wider range of fat-fractions is seen in patients with
a BMI above 25 kg/m2.

MRI fat-fractions is y ¼ 0.0336x þ 32.206, with an r2
value of 0.0011 (plot not shown).
DISCUSSION
In this work, we have evaluated the precision and accuracy of a T1-independent, T2 -corrected chemical
shift based water–fat separation method that uses
multi-peak spectral modeling of fat and eddy current
correction, using MRS as the reference standard. Our
results indicate that hepatic fat-fraction measured
with MRI is both precise and accurate. True changes
in hepatic fat-fraction exist when longitudinal differences are outside the interval [2.66%, 2.64%] for
side-by-side single ROI measurements, [0.81%,
0.80%] for a weighted average of nine ROI measurements across the liver, or [2.69%, 2.87%] for a single
MRS measurement. The precision of a single MRS
measurement is similar to that of the side-by-side
precision, as only one measurement is taken in the
liver for each method, and MRS precision is similar to
that described by van Werven et al (40). As seen in
this study, MRI fat-fractions have similar or better
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precision than MRS fat-fraction imaging. Furthermore, the precision determined by Bland-Altman
analysis is supported by the concordance correlation
coefﬁcients, which are all greater than 0.97. For MRS
or MRI, these intervals may prove useful for noninvasive longitudinal treatment monitoring of NAFLD to
determine whether an observed change is meaningful,
and establishment of these intervals to analyze the
longitudinal precision of hepatic fat quantiﬁcation
was the primary aim of this work.
In addition, fat-fractions measured with MRI was
shown to be as accurate as that measured with MRS.
To the best of our knowledge, this is the ﬁrst study
that has performed validation studies of both the precision and accuracy of a quantitative MRI method
that corrects for the combination of T1 bias, noise
bias, T2 decay, spectral model of fat, and the effects of
eddy currents in patients. Furthermore, we successfully reproduced the accuracy results that have been
previously reported (25), which was the secondary
aim of this work, and these results show that the
technique is accurate over a larger patient population.
An advantage to using a whole liver imaging method
is that it has the ability to take multiple measurements to improve precision, and an improvement in
the precision of fat-fraction imaging is certainly seen
when multiple ROIs are recorded across the liver. Taking multiple ROIs may be recommended for future clinical use, as it can more accurately assess the liver in the
presence of heterogeneous steatosis and improve precision, although the optimal number and placement of
ROIs has yet to be determined. Furthermore, it is wellknown that steatosis occurs heterogeneously across the
liver (39), and as this technique has been successfully
validated, it can be performed to thoroughly analyze fat
concentration in segments of the liver.
In this work we have also investigated the ability of
MRI to establish a diagnosis of steatosis using MRS as
a reference. Sensitivity and speciﬁcity of MRI fat-fraction measurements at the location of the MRS voxel
were lower than that using average MRI fat-fractions.
This improvement in detection of steatosis from using
averaged fat-fraction measurements may occur
because while the variability of single fat-fraction
measurements at low fat-fraction is small, the averaging operation further improves precision of measurements. While variability of fat-fraction can occur
across the liver, this variability is probably low at fatfractions near 5.56%. The reduction in variability
achieved through averaging multiple ROIs in different
Couinaud segments probably dominates the variability of fat-fraction near the thresh-hold and may
explain why sensitivity and speciﬁcity of averaged
MRI fat-fraction is higher than that from a single ROI
colocalized to the MRS voxel.
Furthermore, this work has established the precision of R2 measurements in the liver that are provided
simultaneously as part of the T2 correction for the fatfraction measurements. For two readers, the limits of
agreement are [17.39 s1, 16.23 s1]; this range
determines the change that must be observed to classify it as a true longitudinal change. Average T2 values
in this study (35.0 6 12.0 ms) are consistent with
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reported values in normal subjects, such as that of
Schwenzer et al (28.1 6 7.1 ms) (41), although a
smaller cohort was used for this work and our study
examined patients with a variety of liver diseases. Of
note, lower correlation and precision was seen
between readers and time points for R2 measurements, which is still under investigation. However, differences in R2 values did not appear to affect the
measured fat-fraction since high correlation and precision are still seen for the fat-fraction results.
A potential limitation of this study was the use of
assumed values of T1 of fat and water for correction of
the residual T1 related bias, beyond that achieved
through use of a small ﬂip angle. If actual T1 values
in patients are different than the assumed values, the
T1 bias correction may be incorrect. However, published values of T1 of fat and water were used in the
calculation of the bias (32). Regardless, without any
T1 correction, the correlation between MRI and MRS
was excellent, with near perfect statistical agreement.
Further optimization between SNR and T1 bias for
SPGR acquisitions is currently being performed, as
higher ﬂip angles are preferred to maximize SNR,
although they lead to greater overestimation of fat.
Another limitation of this study was the lack of biopsy
correlation and the use of MRS as the reference
standard for determination of accuracy. In addition,
no speciﬁc group of patients were recruited for this
study, rather, we recruited ‘‘all-comer’’ patients undergoing routine abdominal MRI examinations. However,
steatosis is a disease feature, not a diagnosis, and is
common to many types of liver disease.
In conclusion, proton density fat-fraction, when
measured with T1 independent, T2 corrected MRI with
multi-peak spectral modeling and eddy current correction is a precise and accurate method to quantify
hepatic fat content, when using T2-corrected MRS as
a reference standard. This method provides reliable in
vivo fat quantiﬁcation in patients and is promising as
a quantitative biomarker of hepatic steatosis.
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